WP3 ‘Technologies and resources’ focuses on the development and validation of relevant assays and their application. It prioritizes innovative large scale and multiplex technologies, so called high-throughput technologies that are able to analyse multiple potential disease causing factors as well as drugs simultaneously on a large scale. This work package is interested in the identification of new disease biomarkers by the quantitative comparison of potential disease causing factors. As an example, differences in disease characterizing protein factors in mice or receptor repertoire abnormalities of immune cells will be compared and interpreted.
Academic WP-leader: Leedert Trouw
EFPIA WP-leader: Wendy Trigona